Combination comprising an iron chelator and an anti-neoplastic agent and use thereof

Details for Australian Patent Application No. 2007247112 (hide)

Owner Novartis AG

Inventors Nick, Hanspeter

Agent Davies Collison Cave

Pub. Number AU-B-2007247112

PCT Pub. Number WO2007/128820

Priority 60/746,788 09.05.06 US

Filing date 8 May 2007

Wipo publication date 15 November 2007

Acceptance publication date 26 August 2010

International Classifications

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/282 (2006.01)

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

27 November 2008 PCT application entered the National Phase

  PCT publication WO2007/128820 Priority application(s): WO2007/128820

26 August 2010 Application Accepted

  Published as AU-B-2007247112

23 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007247115-Cooling system by contact

2007247110-Formation of therapeutic scar using small particles